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INTRODUCTION 
Ankylosing spondylitis (AS) is an 
idiopathic chronic inflammatory disease 
belonging to the group of spondyloarthritides 
associated with HLA B-27 involving 
sacroiliac and axial and also peripheral joints 
and it predominantly affects the spine.
1,2
 It 
also has extra particular involvements such as 
acute anterior uveitis, cardiac conductive 
problem, lung upper lobe fibrosis, neurological 
involvement, and amyloidosis.
3-5
 Prevalence 
of AS in northern America is relatively 0.2%
6
 
,and in Europe the frequency of this disorder 
is even more.
7,8
 The related incidence is also 
7.3 to 8.9 per 100,000 subjects every year. 
Male to female ratio is 3-5 to one and the 
clinical manifestations are different between 
the two sexes with less probability of 
progression to vertebral deformity.
9,10
 
AS patients, regarding to multi-system 
involvements, not only experience somatic 
problems but also psychological problems and 
totally their life quality may be decreased.
11,12
 
So, rapid diagnosis and treatment in each 
system is crucial.
13,14
 However, the immune 
dysfunction is the hallmark of Ankylosing 
spondylitis, it may affect important vital 
organs such as cardiovascular system. The 
primary site of inflammation in AS is the 
entheses, the sites of insertion of tendons and 
ligaments into the bone. The importance is 
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ABSTRACT 
Background and aims: Ankylosing spondylitis (AS) is an idiopathic chronic 
inflammatory disease mainly involves sacroiliac and axial joints; but it may also have 
extra-articular involvement. Accordingly, this study was designed to determine the 
frequency of cardiac involvement among patients with ankylosing spondylitis. 
Methods: This study was performed as a descriptive-analytical cross-sectional survey. In 
this study 50 consecutive patients with AS and 40 normal healthy subjects were enrolled 
and compared for cardiologic manifestations. 
Results: The frequency of cardiac involvement was similar between AS patients and 
normal subjects (P>0.05). However, there was significant difference between 2 groups in 
point of mitral valve prolapse and mitral regurgitation (P<0.05). 
Conclusions: Totally, according to the obtained results, it may be concluded that the 
frequency of cardiac involvement in AS patients and normal subjects were relatively 
similar. 
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also more increased for involvement of 
essential organs such as cardiac system 
due to the decreased morbidity and 
mortality in early-diagnosis cases with 
prompt treatment. Accordingly this study 
was designed to determine the frequency 
of cardiac involvement in patients with 
ankylosing spondylitis. 
 
METHODS 
This observational cross-sectional 
comparative study was performed on 50 
patients with AS (according to New York 
Criteria) attending to three training referral 
health care centre and they were selected in a 
census manner. For all the patients, in their 
visits, clinical examination, laboratory 
assessments especially for HLA-B27, and 
radiographic studies of spinal column and 
sacroiliac joints were performed and the grade 
of disease was determined. 
We also selected a comparison group 
including 40 normal healthy individuals 
among the subjects who associated with 
patients and had no sign or symptom of AS or 
other rheumatologic diseases. The patients in 
two groups were similar for their age, sex, 
smoking status, and background history of 
diseases such as hypertension, ischemic heart 
disease, and diabetes. 
Data analysis was performed among 90 
subjects including 40 subjects in control group 
and 50 AS patients in intervention group. Data 
analysis was performed by SPSS (version 
18.0) software [Statistical Procedures for 
Social Sciences; Chicago, Illinois, USA].  
Chi-Square and independent-sample-T tests 
were used and P values less than 0.05 was 
considered statistically significant. 
 
RESULTS 
The mean (± standard deviation) age of 
control and patients groups were 33.97±10.72 
and 33.65±10.32 years, respectively (P>0.05). 
Thirty seven subjects (92.5%) in comparison 
group and 46 patients (92%) in case group 
were male (P>0.05). The mean (± standard 
deviation) duration of involvement was 
8.6±6.3 years. 
In AS group, 48 patients (96%) had low 
back pain, 43 subjects (86%) had enteritis, 
50 patients (100%) had sacroileitis, and 22 
subjects (44%) had peripheral arthritis. The 
HLA-B27 was positive in 27 patients (54%). 
The involvement was unilateral in one 
patient (2%). The frequency of cardiac 
involvement was similar across the groups 
(Table 1); however, the difference was 
significant for mitral valve prolapse and 
mitral regurgitation (P<0.05). 
 
Table 1: Cardiac involvement in AS patients and comparison groups 
Involvement Type AS Patients Comparison Group P Value 
Aortic Stenosis 3(6%) ----- >0.05 
Aortic insufficiency 3(6%) 2(5%) >0.05 
Mitral Stenosis 1(2%) 1(2.5%) >0.05 
Mitral Regurgitation 9(18%) ----- 0.004 
Mitral Valve Prolapse 11(22%) 2(5%) 0.023 
Tricuspid Stenosis 1(2%) ----- >0.05 
Tricuspid Regurgitation 1(2%) ----- >0.05 
Pulmonary Regurgitation ----- ----- >0.05 
Pulmonary Stenosis 1(2%) ----- >0.05 
Abnormal Electrocadriogram 1(2%)
*
 4(10%)
**
 >0.05 
*As Right bundle branch block; **2 cases of PVC, one case of right bundle branch  
block, and one invert T case 
International Journal of Epidemiologic Research, 2015; 2(2): 78-81. 
80 
DISCUSSION 
Heart involvement is the main cause of 
mortality and morbidity in MS patients.
15
 
This study showed that mitral valve prolapse 
and regurgitation were the only cardiac 
involvements differed between AS patients 
and comparison group. These two 
involvements were also the most common 
ones in AS patients. In the conducted study in 
Turkey
16
 among 88 AS patients, 5.7% had 
mitral valve prolapse and 5.7% and 2.3% had 
mitral regurgitation and aortic insufficiency, 
respectively. The reported frequencies in our 
study were higher. 
In conducted study in Hangary
17
 among 
100 AS patients, 14% had cardiac vulvular 
involvement and 17% had conductive 
disorder. However, in our study the 
frequency of vulvular involvement was 
higher and the conductive disorders were 
less common. Another study in Ireland
18
 
showed that 7 out of 24 AS patients had 
cardiac involvement of which one patient 
had pericardial effusion, three had conductive 
disorder, and 2 had aortic insufficiency. 
These frequencies showed that vulvular 
disorder in their study were lower and the 
conductive disorders were higher. 
In the study performed in the United 
States,
19
 44 AS patients and 25 healthy 
volunteers were compared and it was seen 
that 82% and 27% in patients and control 
groups had aortic valve disorder that the 
observed frequencies were lower in our 
study. Another study in the United States
20
 
demonstrated that 10% and 33% of AS 
patients had aortic valve involvement and 
conductive disorders, but the frequency of 
vulvular disorders was higher in our study and 
the conductive problems were less common. 
A different study
21
 indicated that 5 patients of 
28 AS patients had dilated cardiomyopathy in 
echocardiographic evaluation, although we 
could not integrate the echocardiographic 
findings in our study which was a limitation 
of our study. Also Park et al demonstrated 
that the prevalence of aortic and mitral 
regurgitation was very low and there was no 
significant difference between the control 
and the patient groups.
22
 However, in our 
study the mitral valve regurgitation was 
significantly higher in patients with AS in 
comparison with control subjects. 
 
CONCLUSION 
it may be concluded that the frequency 
of cardiac involvement in AS and normal 
subjects was similar, but some types such as 
mitral regurgitation and mitral valve 
prolapse were more common among AS 
patients compared with normal healthy 
subjects. However, further studies are 
required for certification of our findings in 
current study. 
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